The economic burden of respiratory diseases: lung cancer and oxygen treatment

Alain Vergnenègre, Isabelle Borget, Christos Chouaïd

Source: Eur Respir Monogr 2014; 65: 106-115
Journal Issue: Respiratory Epidemiology

Full text journal articleCongress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Alain Vergnenègre, Isabelle Borget, Christos Chouaïd. The economic burden of respiratory diseases: lung cancer and oxygen treatment. Eur Respir Monogr 2014; 65: 106-115

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The economic burden of respiratory diseases: COPD and asthma
Source: Eur Respir Monogr 2014; 65: 116-124
Year: 2014


The occupational burden of respiratory diseases
Source: Annual Congress 2009 - Best of ERS
Year: 2009


The global burden of chronic respiratory diseases
Source: ISSN=ISSN 1810-6838, ISBN=, page=20
Year: 2006

Lung cancer: the importance of seeing a respiratory physician
Source: Eur Respir J 2003; 21: 606-610
Year: 2003



The association between lung function in adults and future burden of obstructive lung diseases in a long-term follow-up
Source: Virtual Congress 2020 – Diagnosis and management of airways disease in primary care
Year: 2020




Prevalence and burden of bronchiectasis in a lung cancer screening program
Source: International Congress 2019 – Airway infection in COPD
Year: 2019


Does long-term oxygen therapy reduce hospitalisation in hypoxaemic chronic obstructive pulmonary disease?
Source: Eur Respir J 2002; 20: 38-42
Year: 2002



Incidence and outcome of lung cancer in patients with chronic respiratory failure
Source: International Congress 2019 – Biology and prognosis of lung cancer
Year: 2019

The Covid-19 pandemic and lung cancer: psychological and diagnosis impacts
Source: Virtual Congress 2021 – COVID-19 and management of lung cancer
Year: 2021


The burden of obstructive lung diseases
Source: International Congress 2016 – PG1 Asthma and chronic obstructive pulmonary disease
Year: 2016



The burden of obstructive lung diseases
Source: International Congress 2015 – PG2 Asthma and COPD
Year: 2015




Mortality of lung cancer in relation to respiratory symptoms, a 30-year population based study
Source: Annual Congress 2005 - Assessing the relevance of obstructive airway diseases
Year: 2005


Lung cancer: the global burden of the disease
Source: International Congress 2015 – Lung cancer screening: how to implement a comprehensive preventive approach
Year: 2015



The burden of emphysema on lung cancer prognosis
Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity
Year: 2020

Reducing the risk of COPD exacerbations as results of personalized therapy of co-morbidity with upper respiratory tract diseases
Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases
Year: 2019


The evolution of respiratory function testing in paediatric lung diseases
Source: Virtual Congress 2020 – Lung health and respiratory function at all ages
Year: 2020


Treatment of chronic respiratory failure: lung volume reduction surgery versus rehabilitation
Source: Eur Respir J 2003; 22: 47S-56S
Year: 2003



Smoking-related lung diseases: a clinical perspective
Source: Eur Respir J 2010; 35: 231-233
Year: 2010